Related Experiment Videos
Immunohistochemical insights into sickle cell retinopathy
1Wilmer Ophthalmological Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21287-9115.
Current Eye Research
|February 1, 1994
Summary
Sickle cell retinopathy involves fibrin deposition in retinal vessels, linked to elevated PAI-1 activity. This may drive choroidal neovascularization and fibrosis through altered growth factor expression.
Area of Science:
- Ophthalmology
- Hematology
- Pathology
Background:
- Sickle cell retinopathy is characterized by dynamic vaso-occlusive and vaso-proliferative events.
- Understanding the molecular mechanisms underlying these changes is crucial for therapeutic development.
Observation:
- Investigated fibrinolytic system components and growth factors in sickle cell retinopathy patients.
- Compared antigen localization in sickle cell patients (SS and SC) with non-sickle cell controls.
Findings:
- Elevated plasminogen activator inhibitor-1 (PAI-1) immunoreactivity in retinal vessel walls of sickle cell patients.
- Fibrin deposition observed within retinal and choroidal vessels, often associated with elevated PAI-1.
- Increased von Willebrand's factor (vWf) and basic fibroblast growth factor (bFGF) in sickle cell choriocapillaris and retinal vessels.
- Reduced transforming growth factor-beta 1 (TGF-beta 1) in sickle cell choriocapillaris.
- bFGF and TGF-beta expression found in migrating retinal pigment epithelial (RPE) cells in lesions.
Implications:
- Elevated PAI-1 may contribute to fibrin deposition and vaso-occlusion in sickle cell retinopathy.
- Vaso-occlusion in choroidal vessels could alter growth factor expression, potentially stimulating choroidal neovascularization (CNV).
- RPE-derived growth factors may promote fibrosis and gliosis in retinal lesions associated with sickle cell disease.